Mesoblast (MESO) Short term Debt (2018 - 2025)
Mesoblast's (MESO) quarterly Short term Debt came in at $66.7 million in Q4 2025, down 34.23% year-on-year from $101.5 million in Q4 2024, and down 1.48% quarter-over-quarter from $67.7 million in Q2 2025.
Mesoblast (MESO) Short term Debt (2018 - 2025) Analysis & Trends
Mesoblast has disclosed Short term Debt across 8 years of filings, most recently posting $66.7 million for Q4 2025.
- Short term Debt for Q4 2025 came in at $66.7 million, down 34.23% year-over-year; the trailing twelve-month figure through Dec 2025 was $66.7 million (down 34.23% YoY), and the FY2025 annual result was $67.7 million, up 388.67% from the prior year.
- Short term Debt came in at $66.7 million for Q4 2025 at Mesoblast, down from $67.7 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $107.2 million in Q4 2023 to a low of $5.0 million in Q2 2022.
- The 5-year median for Short term Debt is $67.7 million (2025), against an average of $66.2 million.
- Across the five-year window, Short term Debt sank 90.57% in 2022 and surged 388.67% in 2025, its largest moves.
- Mesoblast's Short term Debt stood at $86.5 million in 2021, then advanced by 12.07% to $97.0 million in 2022, then advanced by 10.56% to $107.2 million in 2023, then slipped by 5.37% to $101.5 million in 2024, then plunged by 34.23% to $66.7 million in 2025.
- The last three Short term Debt figures came in at $66.7 million (Q4 2025), $67.7 million (Q2 2025), and $101.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.74 Mn |
| Jun 30, 2025 | 67.74 Mn |
| Dec 31, 2024 | 101.48 Mn |
| Jun 30, 2024 | 13.86 Mn |
| Dec 31, 2023 | 107.23 Mn |
| Jun 30, 2023 | 5.95 Mn |
| Mar 31, 2023 | 99.04 Mn |
| Dec 31, 2022 | 96.98 Mn |
| Sep 30, 2022 | 94.19 Mn |
| Jun 30, 2022 | 5.02 Mn |
| Mar 31, 2022 | 88.65 Mn |
| Dec 31, 2021 | 86.54 Mn |
| Sep 30, 2021 | 53.85 Mn |
| Jun 30, 2021 | 53.20 Mn |
| Mar 31, 2021 | 52.67 Mn |
| Dec 31, 2020 | 49.09 Mn |
| Sep 30, 2020 | 56.10 Mn |
| Jun 30, 2020 | 57.02 Mn |
| Mar 31, 2020 | 59.95 Mn |
| Dec 31, 2019 | 66.00 Mn |